Literature DB >> 27177689

Preclinical Medication Development: New Targets and New Drugs.

Chelsea R Kasten1, Stephen L Boehm1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27177689      PMCID： PMC4930385          DOI： 10.1111/acer.13105

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN： 0145-6008            Impact factor:   3.455


× No keyword cloud information.
  43 in total

1.  A double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate XR in very heavy-drinking alcohol-dependent patients.

Authors:  Raye Z Litten; Joanne B Fertig; Daniel E Falk; Megan L Ryan; Margaret E Mattson; Joseph F Collins; Cristin Murtaugh; Domenic Ciraulo; Alan I Green; Bankole Johnson; Helen Pettinati; Robert Swift; Maryam Afshar; Mary F Brunette; Nassima A-D Tiouririne; Kyle Kampman; Robert Stout
Journal:  Alcohol Clin Exp Res       Date:  2011-09-26       Impact factor: 3.455

2.  Regional heterogeneity for the intracranial self-administration of ethanol within the ventral tegmental area of female Wistar rats.

Authors:  Z A Rodd-Henricks; D L McKinzie; R S Crile; J M Murphy; W J McBride
Journal:  Psychopharmacology (Berl)       Date:  2000-04       Impact factor: 4.530

Review 3.  Neurocircuitry for modeling drug effects.

Authors:  Hamid R Noori; Rainer Spanagel; Anita C Hansson
Journal:  Addict Biol       Date:  2012-09       Impact factor: 4.280

4.  PPAR Agonists: II. Fenofibrate and Tesaglitazar Alter Behaviors Related to Voluntary Alcohol Consumption.

Authors:  Yuri A Blednov; Mendy Black; Jillian M Benavidez; Eleni E Stamatakis; R Adron Harris
Journal:  Alcohol Clin Exp Res       Date:  2016-02-09       Impact factor: 3.455

Review 5.  Barriers to use of pharmacotherapy for addiction disorders and how to overcome them.

Authors:  Elizabeth M Oliva; Natalya C Maisel; Adam J Gordon; Alex H S Harris
Journal:  Curr Psychiatry Rep       Date:  2011-10       Impact factor: 5.285

6.  Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial.

Authors:  James C Garbutt; Alexei B Kampov-Polevoy; Robert Gallop; Linda Kalka-Juhl; Barbara A Flannery
Journal:  Alcohol Clin Exp Res       Date:  2010-11       Impact factor: 3.455

7.  Establishing the feasibility of measuring performance in use of addiction pharmacotherapy.

Authors:  Cindy Parks Thomas; Deborah W Garnick; Constance M Horgan; Kay Miller; Alex H S Harris; Melissa M Rosen
Journal:  J Subst Abuse Treat       Date:  2013-03-13

8.  A human laboratory pilot study with baclofen in alcoholic individuals.

Authors:  Lorenzo Leggio; William H Zywiak; John E McGeary; Steven Edwards; Samuel R Fricchione; Jessica R Shoaff; Giovanni Addolorato; Robert M Swift; George A Kenna
Journal:  Pharmacol Biochem Behav       Date:  2012-12-19       Impact factor: 3.533

9.  Zonisamide, topiramate, and levetiracetam: efficacy and neuropsychological effects in alcohol use disorders.

Authors:  Clifford M Knapp; Domenic A Ciraulo; Ofra Sarid-Segal; Mark A Richardson; Eric Devine; Chris C Streeter; Marlene Oscar-Berman; Caitlin Surprise; Laurie Colaneri; Meghan Putnam; Megan Waters; Courtney Richambault
Journal:  J Clin Psychopharmacol       Date:  2015-02       Impact factor: 3.153

Review 10.  Peroxisome proliferator-activated receptor (PPAR) agonists as promising new medications for drug addiction: preclinical evidence.

Authors:  Bernard Le Foll; Patricia Di Ciano; Leigh V Panlilio; Steven R Goldberg; Roberto Ciccocioppo
Journal:  Curr Drug Targets       Date:  2013-06       Impact factor: 3.465
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.